Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**Selenoprotein K pseudogene 1 (SELENOKP1)** is a pseudogene; that is, a DNA sequence that closely resembles the functional selenoprotein K gene (SELENOK) but is rendered non-functional typically due to mutations that prevent transcription or translation[4]. SELENOKP1 does not encode an active protein product or participate in canonical biological pathways or drug interactions. Pseudogenes, by definition, are generally not considered therapeutic targets because they do not produce functional proteins[4]. While its parental gene, Selenoprotein K (SELENOK), is involved in immune response and the endoplasmic reticulum-associated degradation of misfolded proteins[1][5], the pseudogene does not have those properties or roles. The existence of SELENOKP1 is noted as a nonfunctional genetic element and not as a biological or therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Selenoprotein K pseudogene 1 (SELENOKP1).